Literature DB >> 10439047

The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas.

S Klugbauer1, H M Rabes.   

Abstract

Children exposed to radioactive iodine as a consequence of the Chernobyl reactor accident have an increased risk of papillary thyroid carcinomas (PTC). The predominant molecular lesions in these tumors are rearrangements of the RET receptor tyrosine kinase (tk). Here we report on two novel types of RET rearrangement, PTC6 and 7, and describe the fusion products and the ret fused gene (rfg) proteins. Like the other rfg proteins identified so far they are ubiquitously expressed, not membrane-bound and contain coiled coil domains required for constitutive activation of the ret tk domain. In the PTC6 rearrangement the ret tk domain is fused to the aminoterminal part of the human transcription intermediary factor htif 1. In the PTC7 rearrangement the ret tk domain is fused to a novel protein that is strongly related to htif1. Like htif1 it contains a RBCC motif (ring finger, B boxes, coiled coil domain) located in the aminoterminal part and a phd finger and a bromodomain in the carboxyterminal part. Htif1 and related proteins are transcription coactivators for nuclear receptors, thus participating in controlling cellular development, differentiation and homeostasis. This is the first report on their involvement in human thyroid carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10439047     DOI: 10.1038/sj.onc.1202824

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  43 in total

1.  Ret finger protein inhibits muscle differentiation by modulating serum response factor and enhancer of polycomb1.

Authors:  H J Kee; J-R Kim; H Joung; N Choe; S E Lee; G H Eom; J C Kim; S H Geyer; M Jijiwa; T Kato; K Kawai; W J Weninger; S B Seo; K-I Nam; M H Jeong; M Takahashi; H Kook
Journal:  Cell Death Differ       Date:  2011-06-03       Impact factor: 15.828

2.  TRIM24 is upregulated in human gastric cancer and promotes gastric cancer cell growth and chemoresistance.

Authors:  Zhi-Feng Miao; Zhen-Ning Wang; Ting-Ting Zhao; Ying-Ying Xu; Jian-Hua Wu; Xing-Yu Liu; Hao Xu; Yi You; Hui-Mian Xu
Journal:  Virchows Arch       Date:  2015-02-28       Impact factor: 4.064

3.  Gene expression in papillary thyroid carcinoma reveals highly consistent profiles.

Authors:  Y Huang; M Prasad; W J Lemon; H Hampel; F A Wright; K Kornacker; V LiVolsi; W Frankel; R T Kloos; C Eng; N S Pellegata; A de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

4.  Imbalanced expression of Tif1γ inhibits pancreatic ductal epithelial cell growth.

Authors:  Martin Ligr; Xinyu Wu; Garrett Daniels; David Zhang; Huamin Wang; Cristina Hajdu; Jinhua Wang; Ruimin Pan; Zhiheng Pei; Lanjing Zhang; Marcovalerio Melis; Matthew R Pincus; John K Saunders; Peng Lee; Ruliang Xu
Journal:  Am J Cancer Res       Date:  2014-05-26       Impact factor: 6.166

5.  Genome-wide appraisal of thyroid cancer progression.

Authors:  Volkert B Wreesmann; Ronald A Ghossein; Snehal G Patel; Charles P Harris; Erik A Schnaser; Ashok R Shaha; R Michael Tuttle; Jatin P Shah; Pulivarthi H Rao; Bhuvanesh Singh
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

6.  Common properties of nuclear body protein SP100 and TIF1alpha chromatin factor: role of SUMO modification.

Authors:  J S Seeler; A Marchio; R Losson; J M Desterro; R T Hay; P Chambon; A Dejean
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

7.  Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas.

Authors:  Alexander Drilon; Lu Wang; Adnan Hasanovic; Yoshiyuki Suehara; Doron Lipson; Phil Stephens; Jeffrey Ross; Vincent Miller; Michelle Ginsberg; Maureen F Zakowski; Mark G Kris; Marc Ladanyi; Naiyer Rizvi
Journal:  Cancer Discov       Date:  2013-03-26       Impact factor: 39.397

8.  A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype.

Authors:  Yosef Buganim; Ido Goldstein; Doron Lipson; Michael Milyavsky; Sylvie Polak-Charcon; Corine Mardoukh; Hilla Solomon; Eyal Kalo; Shalom Madar; Ran Brosh; Marina Perelman; Roy Navon; Naomi Goldfinger; Iris Barshack; Zohar Yakhini; Varda Rotter
Journal:  PLoS One       Date:  2010-03-11       Impact factor: 3.240

Review 9.  Central role of RET in thyroid cancer.

Authors:  Massimo Santoro; Francesca Carlomagno
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-12-01       Impact factor: 10.005

10.  Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas.

Authors:  David F Vincent; Kai-Ping Yan; Isabelle Treilleux; Fabien Gay; Vanessa Arfi; Bastien Kaniewski; Bastien Kaniewsky; Julien C Marie; Florian Lepinasse; Sylvie Martel; Sophie Goddard-Leon; Juan L Iovanna; Pierre Dubus; Stéphane Garcia; Alain Puisieux; Ruth Rimokh; Nabeel Bardeesy; Jean-Yves Scoazec; Régine Losson; Laurent Bartholin
Journal:  PLoS Genet       Date:  2009-07-24       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.